Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
VANCOUVER, British Columbia & GRAPEVINE, Texas — Alpha Cognition Inc. (NASDAQ: ACOG) (“Alpha Cognition”, “ACI”, or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, today announced that on August 31st, 2026, the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) granted inducement awards…
VANCOUVER, British Columbia and GRAPEVINE, Texas -- Alpha Cognition Inc., a biopharmaceutical company focusing on developing therapeutics for neurodegenerative disorders, announced on August 31st, 2026 that its Compensation Committee granted inducement awards to a new non-executive employee. The awards consist of nonstatutory stock options allowing the employee to purchase 20,000 shares of the company's common stock.
The 2026 Inducement Grant Plan is specifically designed for equity awards granted to individuals who have not previously worked for the company. The Compensation Committee approved the stock options as an inducement to motivate the new employee to join the company, in compliance with Nasdaq Listing Rule 5635(c)(4).
Written by urgent.news from Financial Post's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
